Navigation Links
Three Prize Winners Awarded in Elsevier's Article 2.0 Contest
Date:3/31/2009

AMSTERDAM, March 31 /PRNewswire-FirstCall/ --

- "Thinking Outside the Box" Yields web 3.0, Nonlinear and Smartphone Applications

Elsevier, a leading global healthcare and scientific publisher, has announced the winners in the Elsevier Article 2.0 Contest ( http://www.article20.elsevier.com), a competition challenging individuals to develop creative and useful solutions for rendering journal articles on the web. The contest attracted interest from contestants across the globe with submissions including web, mobile and desktop applications. The panel of seven distinguished judges, drawn from academia, publishing, policymaking and media, considered how each application improved on the existing online presentation of research articles. Special attention was paid to contestants' ability to 'think outside of the box' as well as ease of use and the overall quality of the application.

The $4,000 first prize was awarded to Inigo Surguy whose idea demonstrated how Web 1.0, Web 2.0 and Web 3.0/Semantic Web approaches can be combined to add value to article content. His application enhances content navigation, facilitating commentary on specific paragraphs, and assertions about the article and its contents.

The $2,000 second prize was awarded to Jacek R. Ambroziak. His mobile application enables reading Elsevier articles on an Android Smartphone. Stuart Chalk, the $1000 third prize winner, submitted an idea operating on the premise that research articles are inherently non-linear and that researchers view articles in a random fashion, depending on their interests.

"It is exciting to see the article beginning to emerge as a real digital artefact, using XML to create more than just an enhancement of the print version, and addressing the problems of different digital distribution channels like mobile for the first time," remarked David R. Worlock, Chief Research Fellow, Outsell Inc., and one of the seven Article 2.0 Contest Judges, " But these are just the first steps in what will ultimately be a complete redesign of scholarly communication in the networks."

The panel of Article 2.0 judges also included: Alan Darnell, Manager of the Scholars Portal Project; Dave Kellogg, Chief Executive Officer of MarkLogic; Dr. Donald Lindberg, Director of the National Library of Medicine; Jill O'Neil, Director, Planning and Communication, National Federation of Abstracting and Information Services; Andrew Perry, Postdoctoral Researcher of the University of Melbourne; and Rafael Sidi, Vice President of Product Management, ScienceDirect, Elsevier.

"The Article 2.0 Contest has been another opportunity for Elsevier to collaborate with researchers and developers by providing the building blocks to achieve innovative outcomes", said Darin McBeath, Director of Disruptive Technologies, based in Cincinnati, Ohio.

This initiative reflects Elsevier's goal of getting closer to customers and delivering innovative online tools to increase productivity. Another key innovation contest, The Elsevier Grand Challenge: Knowledge Enhancement in the Life Sciences (http://www.elseviergrandchallenge.com) will be announcing its Grand prize winners from among four finalists at the Experimental Biology Meeting (http://www.eb2009.org) on April 21st. These winners promise new ways of enhancing deep value in scientific content. Over the course of the past year, the Grand Challenge has invited members of the scientific community to describe and prototype tools to improve the interpretation and identification of meaning in online journals and text databases relating to the life sciences.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult ( http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Anna Hogrebe
    Tel: +31-20-485-3269
    newsroom@elsevier.com

   Contact:  Anna Hogrebe, Tel: +31-20-485-3269, newsroom@elsevier.com

'/>"/>
SOURCE Elsevier
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. US Oncology Wins Three National Safety Council Awards
2. Three New Trustees Named By March of Dimes Foundation
3. Three Johns Hopkins researchers named Howard Hughes Medical Institute early career scientists
4. Avidas(TM) Pharmaceuticals Introduces Scalacort(TM) DK Which Offers Three Scalp Solutions in One Patient Convenience Kit
5. Three New NextCare Immediate Care Clinic Locations Open in Colorado
6. Leader in Health Plan Cost Containment Cites Three Economy-Driven Reasons Why Self-Insured Health Plans Should Brace for Claim Increases and Fund Reserves Accordingly
7. Health Career Agents Announces Three Options for Involvement in Health Care Recruiting and Staffing
8. Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors
9. Living With Grief: Diversity and End-of-Life Care' National Teleconference Offered at Three Bay Area Locations
10. Promising Three-year Data: Saving Limbs With Drug-Eluting Stents
11. Three Cetaphil(R) Products Awarded National Eczema Association Seal of Acceptance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: